Neurogene Inc.
USD26.14
-1.40 (-5.08%)
CEO
Rachel L. McMinn
IPO Date
2014-03-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$27.19
Prev. Close
$27.54
Day Low
$25.76
Day High
$27.50
52W Low
$14.65
52W High
$37.27
Market Cap
$0.41B
Volume
0.11M
| 4,800 |
| $32.44 |
| 7 May 2026 | Shafer Christina | Chief Commercial Officer | A-Award | Acquired | 120,000 | $28.94 |
| 20 Apr 2026 | Shafer Christina | officer | Disposed | 0 | $0.00 |
| 30 Mar 2026 | Cvijic Christine Mikail | President and CFO | S-Sale | Disposed | 2,558 | $21.62 |
| 30 Mar 2026 | McMinn Rachel | director, officer: Chief Executive Officer | S-Sale | Disposed | 3,352 | $22.07 |
| 30 Mar 2026 | Jordan Julie | Chief Medical Officer | S-Sale | Disposed | 828 | $21.89 |
| 17 Mar 2026 | Cobb Stuart | Chief Scientific Officer | S-Sale | Disposed | 3,991 | $20.41 |
| 17 Mar 2026 | Cobb Stuart | Chief Scientific Officer | S-Sale | Disposed | 2,658 | $21.34 |
| 17 Mar 2026 | Cobb Stuart | Chief Scientific Officer | S-Sale | Disposed | 148 | $22.08 |